These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 34779207)
1. Development of a DNA Aptamer against Multidrug-Resistant Hepatocellular Carcinoma for Zhang L; Zhou L; Zhang H; Zhang Y; Li L; Xie T; Chen Y; Li X; Ling N; Dai J; Sun X; Liu J; Zhao J; Peng T; Ye M ACS Appl Mater Interfaces; 2021 Nov; 13(46):54656-54664. PubMed ID: 34779207 [TBL] [Abstract][Full Text] [Related]
2. Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers. Rong Y; Chen H; Zhou XF; Yin CQ; Wang BC; Peng CW; Liu SP; Wang FB Oncotarget; 2016 Feb; 7(7):8282-94. PubMed ID: 26882565 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of Polo-Like Kinase 1 by BI2536 Reverses the Multidrug Resistance of Human Hepatoma Cells In Vitro and In Vivo. Li HY; Luo F; Li XY; Fu XF; He JF; Tian YZ; Zhu JJ; Chu XY; Zhao HL Anticancer Agents Med Chem; 2019; 19(6):740-749. PubMed ID: 30836927 [TBL] [Abstract][Full Text] [Related]
4. Screening and verification of ssDNA aptamers targeting human hepatocellular carcinoma. Lu B; Wang J; Zhang J; Zhang X; Yang D; Wu L; Luo Z; Ma Y; Zhang Q; Ma Y; Pei X; Yu H; Liu J Acta Biochim Biophys Sin (Shanghai); 2014 Feb; 46(2):128-35. PubMed ID: 24300391 [TBL] [Abstract][Full Text] [Related]
5. Lenvatinib and Cu Xu Q; Li Q; Yang Z; Huang P; Hu H; Mo Z; Qin Z; Xu Z; Chen T; Yang S J Mater Chem B; 2021 Dec; 9(48):9908-9922. PubMed ID: 34842266 [TBL] [Abstract][Full Text] [Related]
6. A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma. Wang Y; Liu Y; Liu Y; Zhou W; Wang H; Wan G; Sun D; Zhang N; Wang Y Int J Pharm; 2015 Apr; 483(1-2):89-100. PubMed ID: 25681730 [TBL] [Abstract][Full Text] [Related]
7. In vitro selection of aptamer S1 against MCF-7 human breast cancer cells. Zhang WY; Chen HL; Chen QC Bioorg Med Chem Lett; 2019 Aug; 29(16):2393-2397. PubMed ID: 31196711 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma. Fan X; Deng J; Shi T; Wen H; Li J; Liang Z; Lei F; Liu D; Zhang H; Liang Y; Hao X; Wang Z Bioorg Chem; 2021 Sep; 114():105154. PubMed ID: 34378540 [TBL] [Abstract][Full Text] [Related]
9. Selection and characterization of novel DNA aptamer against colorectal carcinoma Caco-2 cells. Maimaitiyiming Y; Yang C; Wang Y; Hussain L; Naranmandura H Biotechnol Appl Biochem; 2019 May; 66(3):412-418. PubMed ID: 30746785 [TBL] [Abstract][Full Text] [Related]
10. Functional Doxorubicin-Loaded Omega-3 Unsaturated Fatty Acids Nanoparticles in Reversing Hepatocellular Carcinoma Multidrug Resistance. Wang C; Wei X; Shao G Med Sci Monit; 2021 Feb; 27():e927727. PubMed ID: 33524008 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance. Sun Y; Xu H; Chen X; Li X; Luo B Biochem Biophys Res Commun; 2019 Jan; 508(2):626-632. PubMed ID: 30522865 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma. Park SY; Han J; Kim JB; Yang MG; Kim YJ; Lim HJ; An SY; Kim JH Eur J Cancer; 2014 Jan; 50(2):341-50. PubMed ID: 24161763 [TBL] [Abstract][Full Text] [Related]
13. Cell-SELEX based selection and characterization of DNA aptamer recognizing human hepatocarcinoma. Ninomiya K; Kaneda K; Kawashima S; Miyachi Y; Ogino C; Shimizu N Bioorg Med Chem Lett; 2013 Mar; 23(6):1797-802. PubMed ID: 23403083 [TBL] [Abstract][Full Text] [Related]
14. The Antitumor Effects of Britanin on Hepatocellular Carcinoma Cells and its Real-Time Evaluation by In Vivo Bioluminescence Imaging. Li H; Du G; Yang L; Pang L; Zhan Y Anticancer Agents Med Chem; 2020; 20(9):1147-1156. PubMed ID: 32106805 [TBL] [Abstract][Full Text] [Related]
15. Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells. Dong J; Zhai B; Sun W; Hu F; Cheng H; Xu J PLoS One; 2017; 12(9):e0185088. PubMed ID: 28934275 [TBL] [Abstract][Full Text] [Related]
16. A branched small molecule-drug conjugate nanomedicine strategy for the targeted HCC chemotherapy. Li SS; Zhang CM; Wu JD; Liu C; Liu ZP Eur J Med Chem; 2022 Jan; 228():114037. PubMed ID: 34883290 [TBL] [Abstract][Full Text] [Related]
17. MRI-visible and pH-sensitive micelles loaded with doxorubicin for hepatoma treatment. Li B; Cai M; Lin L; Sun W; Zhou Z; Wang S; Wang Y; Zhu K; Shuai X Biomater Sci; 2019 Mar; 7(4):1529-1542. PubMed ID: 30681081 [TBL] [Abstract][Full Text] [Related]
18. Multifunctional self-assembled micelles of galactosamine-hyaluronic acid-vitamin E succinate for targeting delivery of norcantharidin to hepatic carcinoma. Jiang S; Li M; Hu Y; Zhang Z; Lv H Carbohydr Polym; 2018 Oct; 197():194-203. PubMed ID: 30007605 [TBL] [Abstract][Full Text] [Related]
19. Aptamer Generated by Cell-SELEX for Specific Targeting of Human Glioma Cells. Lin N; Wu L; Xu X; Wu Q; Wang Y; Shen H; Song Y; Wang H; Zhu Z; Kang D; Yang C ACS Appl Mater Interfaces; 2021 Mar; 13(8):9306-9315. PubMed ID: 33030015 [TBL] [Abstract][Full Text] [Related]
20. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide. Zhao L; Liang L; Guo M; Li M; Yu X; Wang Y; Wang Y Curr Top Med Chem; 2021 Oct; 21(14):1268-1284. PubMed ID: 34620053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]